Join QuartzBio at the 8th Annual Bioinformatics Strategy Meeting East Coast USA for the “Omics-Driven Approaches” track on 23 May 2022. ROUNDTABLE DISCUSSION: “Turning Multi-omic Data Chaos into Translational Insights” Mike Waters of QuartzBio will facilitate a discussion among 10-15 industry leaders around critical topics relevant to biomarker-rich clinical trials:
This author has not written his bio yet.
But we are proud to say that raincastle contributed 57 entries already.
Entries by raincastle
February 18, 2022 — At our first in-person conference in over a year, the QuartzBio team had a chance to connect with biomarker operations and clinical operations teams in Orlando, Florida, earlier this month. In the “Clinical Biomarkers Operations and Innovation” track, we joined discussions on the latest approaches to structuring clinical sample management to […]
February 9, 2022 — Clinical operations leaders use the QuartzBio® virtual Sample Inventory Management (vSIM) solution to maintain robust visibility across sample collection and processing status, consent status, and sample and derivative quality information. Traditionally, generating these reports is frustratingly time-consuming – often involving spreadsheets that attempt to manually link key information from the EDC, […]
Register for the webinar here Title: Keeping Track of Clinical Samples in Biomarker-Rich Clinical Trials Duration: 30 minutes Learn how clinical operations and translational teams are creating “sponsor-centric” visibility to reconcile sample status and location on-study.
Join QuartzBio at the SCOPE 2022 Summit for the “Clinical Biomarkers Operations and Innovation” track on February 8-9. PRESENTATION: “30 Days to an Annotated Virtual Repository — Without Changing DTAs” Clinical and biomarker operations teams can create ongoing visibility into sample collection, processing and testing by linking biospecimen metadata, informed consent, and biomarker data across […]
January 10, 2022 — With immuno-oncology assets progressing in the clinic, a growing biotechnology company we work with faces an increasingly common challenge: Their trials are generating large datasets across a wide range of assay modalities (Figure 1), but the data remains siloed. In addition to clinical data coming from the clinical research organization (CRO), […]
November 19, 2021 — As we discussed in our recent webinar, QuartzBio’s virtual Sample Inventory Management (vSIM) solution empowers clinical operations and translational research teams by integrating multiple sources of sample information, both within and across studies. The platform enables users to interact with harmonized data from multiple sources, gain critical insights via KPI and […]
Register for the webinar here Title: Advancing Clinical Sample Management with a Virtual Sample Repository Duration: 30 minutes You’ll see how a virtual repository delivered via QuartzBio’s translational hub provides visibility into clinical sample status: Sample visibility across studies, central labs, third party vendors, biorepositories, and disparate source systems KPI dashboards that report sample status including […]
October 8, 2021 — Sponsors are challenged to keep track of complex sample inventories, both on study and for samples collected as part of completed studies that might be later mined for translational research needs. We frequently hear that teams spend significant time manually cross-referencing spreadsheets of inventory data, to answer questions such as: “How […]
August 31, 2021 — Clinical samples are moving across an increasing number of physical/virtual locations and data is delivered in an expanding array of file formats as clinical trials become increasingly more complex and data rich (report). Biospecimens are analyzed using a variety of assay technologies, each generating its own set of reportables, quality control […]
Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.
QUARTZBIO® and the PRECISION QUARTZBIO logo® are registered trademarks of Precision Medicine Group, LLC in the United States and/or other jurisdictions. All rights reserved. The names and logos of other companies and products appearing on the website may be trademarks or registered trademarks of such other companies.